Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Stanley N Caroff"'
Autor:
Jamir Pitton Rissardo, Krish Kherajani, Nilofar Murtaza Vora, Venkatesh Yatakarla, Ana Letícia Fornari Caprara, Jeffrey Ratliff, Stanley N. Caroff
Publikováno v:
Medicina, Vol 60, Iss 8, p 1347 (2024)
Background and Objectives: Vertical rhythmic dyskinetic movements that are primarily drug-induced and affect solely the jaw, mouth, and lips without involving the tongue have been historically described as “rabbit” syndrome (RS). Evidence on the
Externí odkaz:
https://doaj.org/article/a241595df4534ccfbbf84003111ffc62
Autor:
Caroline M. Tanner, Stanley N. Caroff, Andrew J. Cutler, William R. Lenderking, Huda Shalhoub, Véronique Pagé, Ericha G. Franey, Michael Serbin, Chuck Yonan
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-11 (2023)
Abstract Background Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with antipsychotic use. Data from RE-KINECT, a real-world study of antipsychotic-treated outpatients, were analyzed to assess the effec
Externí odkaz:
https://doaj.org/article/7624d1f68f3346d79bebd79e645eff49
Autor:
Stanley N. Caroff, Christopher B. Roberts, Henry Rosenberg, Joseph R. Tobin, Stacey Watt, Darlene Mashman, Sheila Riazi, Rosalind M. Berkowitz
Publikováno v:
BMC Anesthesiology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Intravenous dantrolene is often prescribed for hypermetabolic syndromes other than the approved indication of malignant hyperthermia (MH). To clarify the extent of and indications for dantrolene use in conditions other than MH, we
Externí odkaz:
https://doaj.org/article/bd5522478214462f84e889f394e38c24
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background The relative benefits and risks of long-term maintenance treatment with antipsychotics have not been well studied in patients with bipolar disorder and major depressive disorder. For example, while antipsychotic dose reduction has
Externí odkaz:
https://doaj.org/article/036d659fd5b141b58c8973ea0f23e0e3
Publikováno v:
World Journal of Psychiatry. 13:131-137
Publikováno v:
BMC Psychiatry, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background Data are limited on the benefits and risks of dose reduction in managing side effects associated with antipsychotic treatment. As an example, antipsychotic dose reduction has been recommended in the management of tardive dyskinesi
Externí odkaz:
https://doaj.org/article/04b9774998494e9b9f9b83570a445680
Autor:
Stanley N. Caroff
Publikováno v:
CNS spectrums.
Tardive dyskinesia (TD) is a heterogeneous, hyperkinetic movement disorder induced by dopamine-receptor blocking agents that presents a unique challenge in the treatment of psychosis. Although acceptance of TD as a serious consequence of antipsychoti
Publikováno v:
Schizophrenia research.
Catatonia is a neuropsychiatric syndrome consisting of psychomotor abnormalities caused by a broad range of disorders affecting brain function. While the nosological status of catatonia is no longer restricted to a subtype of schizophrenia in standar
Publikováno v:
Schizophrenia Research.
While the psychopathology of mental disorders during pregnancy and the postpartum period is a growing area of research, the prevalence and significance of catatonic symptoms has been relatively neglected. To address this gap in knowledge, a systemati
Autor:
E. Cabrina Campbell, Stanley N. Caroff, John Northrop, Alisa R Gutman, Rosalind M Berkowitz, Shirley H. Leong
Publikováno v:
Clinical Psychopharmacology and Neuroscience
Objective Although evidence implicates striatal cholinergic impairment as a mechanism underlying tardive dyskinesia, trials of nonspecific cholinergic agents have been inconclusive. As a partial agonist at specific nicotinic receptor subtypes, vareni